The research activities of the Schizophrenia Center include one NIH-designated research center and a growing number of individual faculty-led research programs which are guided by a unifying vision aimed at discovering the pathological mechanisms of schizophrenia and developing novel ways to treat this devastating illness.
Conte Center for Schizophrenia Research
This research center, which is funded by the P50 NIMH Silvo O. Conte Center Grant ansled by Center Director – Akira Sawa MD, PhD, is a research team dedicated to both the translational and clinical study of schizophrenia. Scientists and clinicians represent multiple departments (psychiatry, neuroscience, human genetics, pediatrics, biostatistics, and psychology) in multiple schools at Johns Hopkins including the schools of Medicine, Public Heath, and Arts and Sciences. Believing that early intervention may be a key to successful therapeutic strategies in schizophrenia , the Center team studies pathological mechanisms of genetic and environmental risk factors in the context of the developmental trajectory of the disease by using multiple research approaches, including genetics, mouse genetic engineering, molecular profiling, immunology, as well as molecular and behavioral neuroscience.
Individual Faculty-Led Laboratories and Research Programs
Epidemiology-Genetics Program – Ann Pulver, Ph.D.
The Kamiya Lab – Atsushi Kamiya, M.D., Ph.D.
The Kano Lab – Shinichi Kano, M.D., Ph.D.
The Margolis Lab – Russell L. Margolis, M.D.
The Sedlak Lab – Thomas Sedlak, M.D., Ph.D.